Newsletter | March 1, 2024

03.01.24 -- The FDA Speaks Up For Quality Management: Must They Beg?

SPONSOR

A Full-Service Solution Partner Disrupting The Outsourcing Paradigm

inSeption Group is a global full-service outsourcing organization that's resurrected a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for their clients who have experienced the progressive degradation of today’s outsourcing options. Contact them.

TRIAL MONITORING

The FDA Speaks Up For Quality Management: Must They Beg?

The FDA's quality by design (QbD) and risk-based monitoring (RBM) messaging began more than 10 years ago with their guidance on RBM. Eleven years, five total related key guidance documents (listed below), and one global pandemic later, why aren’t we moving forward at more than a snail’s pace? 

Lowering TMF Risks: Real-World Use Cases And Lessons Learned

Watch as TMF experts share insights from actual customer engagements and pragmatic tips on how companies large and small have reduced TMF risk with less effort.

Harnessing The Power Of Real-World Data In Clinical Trial Planning

As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.

CLINICAL DATA MANAGEMENT & ANALYTICS

9 Ways Unified Cloud Platforms Solve Data Challenges In Rare Disease

A unified clinical data cloud platform is a data and analytics platform that contains a data hub to aggregate clinical data from multiple data sources and in multiple formats — and it could be the cure for disordered rare disease data.

AI Without The Hype: Realizing High-Value Business Transformations

Read this high-level summary to better understand how artificial intelligence can improve product quality, accelerate decision-making, reduce operational costs, and enable preventive maintenance services.

How Vanguard Clinical Harnesses CDMS/EDC For Faster Results

Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.

Industry-Leading IRB Tech Platform For Predictable Results

Discover a new way to streamline document management and guarantee compliance with regulatory standards, providing a robust and user-friendly solution for optimizing research processes.

Driving Success In Dermatology Drug Development

Our dedicated teams are led by in-house, board-certified dermatologists who have decades of experience conducting early- and late-phase studies. Download the available brochure to learn more.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: